2m 2m 2m 2m 2m 2m 2m
Cannapharmarx (CPMD)
OTC
$0.003+$0.0005 (+25.00%)
Price as of Jun 03, 2026- $1.7MMarket Cap
- -48.98%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Cannapharmarx (CPMD)
$0.003+$0.0005 (+25.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4M +66.09% | 820,137 N/A | 0 N/A | 0 N/A | |
Cost of Revenue | 3.4M -8.20% | 3.8M N/A | N/A N/A | N/A N/A | |
Gross Profit | -2.1M -28.96% | -2.9M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 71,287 -38.88% | 116,640 N/A | 0 -100.00% | 10,886 N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | 0 -100.00% | 127,847 -56.65% | 294,934 N/A | |
Total Operating Expenses | 1.3M +88.11% | 671,330 -57.54% | 1.6M -69.66% | 5.2M +74.12% | |
Operating Profit | -3.3M -7.17% | -3.6M +128.08% | -1.6M -69.66% | -5.2M +74.12% | |
Interest Income | N/A N/A | 0 +100.00% | -78,760 N/A | 0 +100.00% | |
Interest Expense | -2.0M -13.48% | -2.3M +33.90% | -1.7M -26.17% | -2.3M +51.94% | |
Interest Income and Expense and Net | -2.0M -13.48% | -2.3M +27.94% | -1.8M -22.73% | -2.3M -72.00% | |
Total Nonoperating Income and Expense | -7.8M +23.56% | -6.3M -219.55% | 5.3M +258.76% | -3.3M -43.16% | |
Income before Taxes | -3.3M -7.17% | -3.6M +128.08% | -1.6M -81.47% | -8.5M +185.02% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.1M +12.37% | -9.9M -368.56% | 3.7M +143.24% | -8.5M -3.41% | |
Net Income from Continuing Operations Applicable to Common | -11.1M +12.37% | -9.9M -368.56% | 3.7M +143.24% | -8.5M -3.41% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | 0.01 -75.00% | 0.04 N/A | |
Diluted EPS and Net Income | -0.02 0.00% | -0.02 -300.00% | 0.01 -75.00% | 0.04 N/A | |
Basic Weighted Average Shares | 662.5M +5.95% | 625.3M +102.40% | 308.9M +46.39% | 211.0M +182.57% | |
Diluted Weighted Average Shares | 662.5M +5.95% | 625.3M +102.40% | 308.9M +46.39% | 211.0M +182.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1,804 -16.33% | 2,156 +231.69% | 650 -71.95% | 2,317 -91.66% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1,804 -16.33% | 2,156 +231.69% | 650 -71.95% | 2,317 -91.66% | |
Total Current Assets | 1.3M +28.71% | 1.0M -14.80% | 1.2M +1,095.67% | 100,014 +238.59% | |
Accumulated Depreciation | -869,975 -1,281.81% | 73,614 +53.65% | 47,909 +166.07% | 18,006 +251.54% | |
Property and Plant and Equipment and Net | 127,029 -7.44% | 137,237 -15.04% | 161,540 +49.88% | 107,780 +1,686.80% | |
Total Long-Term Assets | 127,029 -7.44% | 137,237 -15.04% | 161,540 +49.88% | 107,780 +1,686.80% | |
Total Assets | 7.0M -35.23% | 10.8M -7.75% | 11.7M +116.94% | 5.4M +4,635.57% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.5M N/A | N/A N/A | 3.3M -56.79% | 7.7M +870.30% | |
Total Current Liabilities | 31.6M +22.67% | 25.8M +41.78% | 18.2M +5.82% | 17.2M +31.63% | |
Total Long-Term Debt | 5.7M -28.41% | 8.0M +424.47% | 1.5M +33.28% | 1.1M -93.44% | |
Total Long-Term Liabilities | 5.0M -27.55% | 6.9M +91.79% | 3.6M -76.53% | 15.4M -6.18% | |
Total Liabilities | 37.2M +21.30% | 30.6M +28.23% | 23.9M +5.01% | 22.8M +74.53% | |
Retained Earnings | -112.3M +11.00% | -101.2M +10.85% | -91.3M -3.61% | -94.7M +9.90% | |
Total Stockholders Equity | -30.2M +52.22% | -19.8M +63.00% | -12.2M -29.93% | -17.3M +34.18% | |
Total Shares Outstanding | 662.5M 0.00% | 662.5M +50.31% | 440.8M +60.79% | 274.1M +118.41% | |
Cash Flow | |||||
Cash from Operating Activities | -789,102 -53.51% | -1.7M -25.38% | -2.3M +57.04% | -1.4M -40.02% | |
Capital Expenditures | 5,519 N/A | 0 -100.00% | 80,634 N/A | N/A N/A | |
Cash from Investing Activities | 794,269 N/A | 0 +100.00% | -80,634 -30.49% | -115,998 -123.50% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -5,519 -100.32% | 1.7M -27.82% | 2.4M +67.54% | 1.4M +4.79% | |
Financials Ratio | |||||
Gross Margin | -153.06% -57.23% | -357.86% N/A | N/A N/A | N/A N/A | |
Operating Margin | -245.77% -44.11% | -439.71% N/A | N/A N/A | N/A N/A | |
Return on Assets | -124.69% +42.13% | -87.73% -304.08% | 42.99% +113.93% | -308.62% +54.82% | |
Return on Equity | 44.56% -28.11% | 61.98% +347.85% | -25.01% -144.37% | 56.37% -30.67% | |
Revenue Growth | 66.09% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.04 +4.80% | 0.04 -39.82% | 0.07 +1,034.48% | 0.006 +152.17% | |
Cash Ratio | 0.0001 0.00% | 0.0001 N/A | 0.00 -100.00% | 0.0001 -95.24% | |
Debt-to-Equity Ratio | -0.24 N/A | N/A N/A | -0.40 -21.76% | -0.51 -63.71% | |
Debt-to-Assets Ratio | 1.03 N/A | N/A N/A | 0.41 -74.74% | 1.64 -98.97% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow